TNFRSF10D is negatively correlated with the biochemical recurrence risk score of prostate cancer, suggesting that the overexpression of TNFRSF10D can reduce the incidence of biochemical recurrence [54]. The gene discussed is TNFRSF10D; the disease is prostate carcinoma.